Skip to main content


Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Table 1 Tukey-honest significant differences post-hoc test for Proseek data [Stage specific (A-D)] and healthy unaffected control (group E)

From: A novel multiplexed immunoassay identifies CEA, IL-8 and prolactin as prospective markers for Dukes’ stages A-D colorectal cancers

Candidate Biomarker Comparison Up/Down of expression Adjusted p-value Previous studies referring CRC associations
CEA D/A 0 [15-21]
  D/E 1.70E-12
  D/B 4.13E-12
  D/C 0.0001
  C/A 0.0076
  C/E 0.0304
IL-8 D/E 1.23E-06 [44,47]
  D/A 2.96E-05  
Prolactin C/D 1.24E-05 [49-51]
  C/E 2.89E-05  
Amphiregulin D/A 8.95E-07 [54]
  D/C 1.46E-06  
PDGF-BB D/A 3.02E-05 [22,55]
IL-6 B/A 0.0024 [43,56]
  B/E 0.0124  
CXCL11 D/C 0.0155 [57]
  D/A 0.0387  
CXCL5 D/A 0.0424 [58-61]